[Seoul, South Korea] 

 Mr. Hyeunseung Roh, Senior Investment Officer at the Swiss Embassy of Korea, recently visited Cellweaverse to discuss opportunities for European expansion.

With extensive experience at multinational pharmaceutical companies such as Eli Lilly, Johnson & Johnson, and Astellas, Mr. Roh specializes 

in supporting pharmaceutical and biotech companies looking to enter the Swiss market.

During his visit, he emphasized the advantages of the Basel region, a major hub for global pharmaceutical companies, and its strong industry network. 

He also expressed his commitment to assisting Cellweaverse in successfully expanding into the European market.

 

As Cellweaverse continues to develop innovative cell-culture-based alternatives for medical and biotech applications, collaborations with global industry leaders 

and government agencies are expected to play a crucial role in the company’s international growth.